Key Executives
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Kevin J. Knopp Ph.D. | Co-Founder, CEO, President & Director | 761.12k | -- | 1972 |
Mr. Joseph H. Griffith IV | CFO & Treasurer | 491.89k | -- | 1975 |
Mr. Michael S. Turner Esq., J.D. | Chief Legal & Administrative Officer and Secretary | 470.65k | -- | 1967 |
Ms. Barbara Russo | VP of Marketing & Corporate Communications | -- | -- | 1963 |
Mr. Don Osmer | Vice President of Human Resources | -- | -- | 1965 |
908 Devices Inc.
- Sector:
- Healthcare
- Industry: Medical Devices
- Full Time Employees:
- 246
Description
908 Devices Inc., a commercial-stage technology company. The company provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. It also provides include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling. Its products also comprise Maven and Trace C2, an online device for bioprocess monitoring and control; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. The company operates in the United States, Europe, the Middle East, Africa, the Asia Pacific, and rest of the Americas. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Corporate Governance
Upcoming Events
April 28, 2025 at 12:30 PM UTC - May 2, 2025 at 12:30 PM UTC
908 Devices Inc. Earnings Date